This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Corebridge (CRBG) Q2 Earnings Top on Premium Growth, Rise Y/Y
by Zacks Equity Research
Corebridge's (CRBG) second-quarter results benefit from growing premiums, deposits and net investment income. Higher benefits expenses partially offset the positives.
Will Higher Benefits Affect Corebridge's (CRBG) Q2 Earnings?
by Zacks Equity Research
Corebridge's (CRBG) second-quarter results are likely to reflect increasing premiums and deposits and base spread income.
The Zacks Analyst Blog Highlights Corebridge Financial, Redfin and Community Health
by Zacks Equity Research
Corebridge Financial, Redfin and Community Health are included in this Analyst Blog.
3 Must-Buy Under $20 Stocks as Inflation Subsides
by Abhinab Dasgupta
CRBG, RDFN and CYH are three of the best and cheapest stocks that have long-term prospects and can be invested in.
Corebridge Financial (CRBG) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Corebridge Financial (CRBG) closed the most recent trading day at $19.35, moving +0.68% from the previous trading session.
Wall Street Analysts Believe Corebridge (CRBG) Could Rally 25.03%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 25% upside potential for Corebridge (CRBG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Corebridge Financial (CRBG) Just Overtook the 200-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 200-day simple moving average?
Zacks Industry Outlook Highlights MetLife, American International Group, Prudential, Assurant and Corebridge Financial
by Zacks Equity Research
MetLife, American International Group, Prudential, Assurant and Corebridge Financial have been highlighted in this Industry Outlook article.
5 Stocks to Watch From the Soft Multiline Insurance Industry
by Tanuka De
Better pricing, product redesigns, technological advancement, high inflation and rate rise are expected to aid multiline insurers like MET, AIG, PRU, AIZ and CRBG.
Can Marsh & McLennan (MMC) Q2 Earnings Beat on Consulting Boost?
by Zacks Equity Research
The second-quarter results of Marsh & McLennan (MMC) are likely to reflect strong international operations in the Risk and Insurance Services unit.
CRBG or BBSEY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CRBG vs. BBSEY: Which Stock Is the Better Value Option?
What's in Store for Nasdaq (NDAQ) This Earnings Season?
by Zacks Equity Research
Nasdaq's (NDAQ) second-quarter performance is likely to have been driven by solid organic revenue growth, strong performance at corporate solutions and analytics businesses and higher market technology revenues.
Will Rising Costs Hurt Discover Financial's (DFS) Q2 Earnings?
by Zacks Equity Research
Discover Financial's (DFS) second-quarter results are likely to reflect higher net interest margins and PULSE and Diners Club volume.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Will Corebridge (CRBG) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Corebridge (CRBG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Rising Costs Affect Synchrony's (SYF) Q2 Earnings?
by Zacks Equity Research
Synchrony's (SYF) second-quarter results are likely to reflect lower net interest margins and higher purchase volume.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
New Strong Buy Stocks for July 10th
by Zacks Equity Research
CRBG, LSF, SMWB, NVCT and WT have been added to the Zacks Rank #1 (Strong Buy) List on July 10, 2023.
Does Corebridge (CRBG) Have the Potential to Rally 34.46% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Corebridge (CRBG) points to a 34.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
CRBG vs. BBSEY: Which Stock Is the Better Value Option?
by Zacks Equity Research
CRBG vs. BBSEY: Which Stock Is the Better Value Option?
AIG Rises 16.4% in Three Months: What's Driving the Stock?
by Zacks Equity Research
AIG's management is working on improving ROCE with the help of cost-curbing efforts, enhancing underwriting profitability and streamlining operations.
The Zacks Analyst Blog Highlights Unum Group, Kinsale Capital, Reinsurance Group of America, RLI and Corebridge Financial
by Zacks Equity Research
Unum Group, Kinsale Capital, Reinsurance Group of America, RLI and Corebridge Financial are included in this Analyst Blog.
5 Momentum Insurance Stocks to Buy for a Stable Portfolio
by Nalak Das
We have narrowed our search to five momentum insurance stocks. These are: UNM, RGA, CRBG, KNSL, RLI.
New Strong Buy Stocks for June 21st
by Zacks Equity Research
WIRE, BTVCY, CVLG, VBNK and CRBG have been added to the Zacks Rank #1 (Strong Buy) List on June 21, 2023.
CRBG or BBSEY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CRBG vs. BBSEY: Which Stock Is the Better Value Option?